A major wave of regulatory change is reshaping the pharmaceutical industry in 2026, and it’s happening across Europe, the UK, the US, and globally. In this session, Dr. Pete Gough (VP & Principal Consultant, NSF Life Sciences) breaks down the most important updates impacting:
- EU pharmaceutical legislation (including 1,000+ pages of new rules)
- GMP changes affecting manufacturing and quality teams
- New responsibilities for Qualified Persons (QPs)
- Decentralised manufacturing and regulatory oversight
- Supply chain risk and mandatory shortage prevention planning
- UK clinical trial and GMP updates
- FDA organisational changes and new initiatives
- Emerging international developments (ICH, African Medicines Agency)
With decades of regulatory intelligence experience, Dr. Gough provides a clear view of what’s changing, why it matters, and how pharma teams should prepare.
If you're in quality, regulatory affairs, or pharmaceutical manufacturing, this session will help you stay ahead of accelerating global change.
